Literature DB >> 23142287

Comprehensive genome sequencing of the liver cancer genome.

Hidewaki Nakagawa1, Tatsuhiro Shibata.   

Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Recently, comprehensive whole genome and exome sequencing analyses for HCC revealed new cancer-associated genes and a variety of genomic alterations. In particular, frequent genetic alterations of the chromatin remodeling genes were observed, suggesting a new potential therapeutic target for HCC. Sequencing analysis has further identified the molecular complexities of multicentric lesions and intratumoral heterogeneity. Detailed analyses of the somatic substitution pattern of the cancer genome and the HBV virus genome integration sites by using whole-genome sequencing will elucidate the molecular basis and diverse etiological factors involved in liver cancer development.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chromatin remodeling; HBV integration; Hepatocellular carcinoma; Intratumoral heterogeneity; Multi-centric; Telomerase reverse transcriptase; Whole exome sequencing; Whole genome sequencing

Mesh:

Substances:

Year:  2012        PMID: 23142287     DOI: 10.1016/j.canlet.2012.10.035

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  26 in total

Review 1.  Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Authors:  Carmen Berasain; María Elizalde; Raquel Urtasun; Josefa Castillo; Oihane García-Irigoyen; Iker Uriarte; Maria U Latasa; Jesús Prieto; Matías A Avila
Journal:  Hepat Oncol       Date:  2014-03-20

2.  Drug development for hepatocellular carcinoma: knowing the past helps to understand the future.

Authors:  Stephen L Chan
Journal:  Oncologist       Date:  2014-09-15

Review 3.  Liver masses: a clinical, radiologic, and pathologic perspective.

Authors:  Sudhakar K Venkatesh; Vishal Chandan; Lewis R Roberts
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-18       Impact factor: 11.382

Review 4.  The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy.

Authors:  Erik S Knudsen; Purva Gopal; Amit G Singal
Journal:  Am J Pathol       Date:  2013-12-31       Impact factor: 4.307

5.  Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma.

Authors:  Jun-Xiong Yu; Qian Chen; Ya-Qun Yu; Shu-Qun Li; Jian-Fei Song
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

Review 6.  Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis.

Authors:  W B Liu; J F Wu; Y Du; G W Cao
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

7.  PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE.

Authors:  Kirti Shetty; Jian Chen; Ji-Hyun Shin; Wilma Jogunoori; Lopa Mishra
Journal:  Curr Hepatol Rep       Date:  2015-06

8.  Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors.

Authors:  Ryugo Teranishi; Tsuyoshi Takahashi; Toshirou Nishida; Seiichi Hirota; Yukinori Kurokawa; Takuro Saito; Kazuyoshi Yamamoto; Kotaro Yamashita; Koji Tanaka; Tomoki Makino; Masaaki Motoori; Takeshi Omori; Kiyokazu Nakajima; Hidetoshi Eguchi; Yuichiro Doki
Journal:  Int J Clin Oncol       Date:  2022-04-18       Impact factor: 3.402

9.  Ring Finger Protein 125 Is an Anti-Proliferative Tumor Suppressor in Hepatocellular Carcinoma.

Authors:  Takahiro Kodama; Michiko Kodama; Nancy A Jenkins; Neal G Copeland; Huanhuan Joyce Chen; Zhubo Wei
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

Review 10.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.